BIOHLDG 0179

BIOHLDG 0179

PREVCLOSECHANGEHIGHCLOSE
0.2550.260+0.0050.2650.255

VOLUMEBUY VOLBUYSELLSELL VOL
126,2675,2300.2600.26522,374

(7 customer reviews)
52 Weeks Range : 0.065 - 0.395

5 day volume Average = 14,650,920
20 day volume Average = 16,791,655
90 day volume Average = 32,650,964
Add to wishlistAdded to wishlistRemoved from wishlist 3
Add to compare
4.1/10 (Expert Score)
Product is rated as #58 in category ACE Market
Prospective Profit
2.400
Assets
2.809
Dividend/ Cash
3.969
Liquidity
7.386
PROS:
  • Positive Cash Company
  • Very Low Gearing
  • Very High Trading Value
CONS:
  • Poor Income Near Future
  • Very Low Price-to-Tangible

klse: Bioalpha Holdings Bhd


Corporate Information

Board   : Ace

Shariah : Shariah Compliant

Sector   : Construction Ringgit Consumer

Address: No 10, Jalan P/9A, Seksyen 13, Bandar Baru Bangi, Bangi, 43650, Selangor

Contact: +603-89251222

Website: https://www.bioa.com.my/
 

Corporate Background

Bioalpha Holdings Berhad manufactures and sells health supplement products. The Company offers health supplement products such as processed herbs, formulated ingredients, and functional foods, as well as herbal and non-herbal supplements. Bioalpha Holdings serves customers in Malaysia.

Specification: BIOHLDG 0179

Market Capital (RM) 288, 722, 416
Forecasted Profit or Loss (RM) 1, 515, 632
Estimated Future EPS (sen) 0.132
Perspective P/E ratio 195.569
Estimated Dividend Yield (%) 0.033
Adjusted NTA (RM) 0.123

Result

Quarter Report History

Date Revenue,k PBT,k Net Profit,k
27/11/20 6,871 -10,441 -9,709
28/08/20 6,392 -8,199 -7,932
25/06/20 6,532 -5,305 -5,503
28/02/20 18,413 3,945 3,033
28/11/19 17,276 3,516 3,105
30/08/19 14,033 2,035 2,034
27/05/19 12,482 1,266 858
28/02/19 17,313 5,287 3,020
26/11/18 20,182 4,407 4,199
23/08/18 19,546 4,086 4,141
28/05/18 12,463 634 640
26/02/18 18,910 5,858 4,433

Fundamental

Fundamental Analysis

Last 4 Quarter Revenue (RM’000) 38,208
Last 4 Quarter Net Profit (RM’000) -21,733
Last 4 Quarter EPS (sen) -2.1
Last 4 Quarter PER
Last 4 Quarter Dividend (sen)
Last 4 Quarter Dividend Yield (%)
Net Tangible Assets (RM) 0.19
Goodwill (RM) 52,800
Cash (RM’000) 15,040
Debt (RM’000) 13,090
Total Debt (RM’000) 28,660
Net Assets (RM’000) 161,620
Current Ratio 7.32
Quick Ratio 6.36
Cash Ratio 1.13

Technical

Technical Analysis

MACD (26 vs 12) -0.006
Exponential Moving Average 5 0.265
Exponential Moving Average 20 0.274
Exponential Moving Average 90 0.267
Relative Strength Index 14 0.23
Stochastic %D 3 0.34
Stochastic %K 14 0.22

7 reviews for BIOHLDG 0179

3.1 out of 5
0
3
3
0
1
Write a review
Show all Most Helpful Highest Rating Lowest Rating
  1. Avatar

    The Edge

    Bioalpha Holdings Bhd has been appointed by Hong Kong-listed Ritamix Global Ltd as a contract manufacturer to make and supply a longevity dietary supplement. They are expecting multi-millions of orders from Ritamix for the Malaysia and China markets. The supplement product contains the nicotinamide mononucleotide (NMN) compound that can help restore energy and reduce typical signs of ageing such as gradual weight gain. Managing director William Hon said he expects NMN products to deliver a gross profit margin of 50% based on the selling price to Ritamix.

    Helpful(1) Unhelpful(0)You have already voted this
  2. Avatar

    The Edge

    Integrated health supplement company Bioalpha Holdings Bhd has proposed a private placement exercise which is estimated to raise up to RM13.77 million. It plans to issue up to 59.86 million new ordinary shares, representing not more than 5% of its enlarged share capital, to raise money for working capital. Assuming full subscription of the placement shares at an indicative price of 23 sen each, the company would raise up to RM13.77 million, Bioalpha said in a filing with Bursa Malaysia today.

    Helpful(2) Unhelpful(0)You have already voted this
  3. Avatar

    The Edge

    Bioalpha Holdings Bhd, which in July signed a RM2.1 billion contract to supply health food to China, recorded sales of over RM1 million from its first delivery made in September. The delivery comprised health food ingredients for the preparation of health food and nutritional meals to be distributed to customers in Guizhou province, the company said in a statement today. The supply contract is valued at 700 million yuan (RM427 million) annually for a duration of five years, subject to annual renewal. This translates into a potential contract value of up to 3.5 billion yuan (RM2.1 billion) over the five-year period.

    Helpful(1) Unhelpful(0)You have already voted this
  4. Avatar

    BURSA MALAYSIA

    The revenue for the Q2 2020 decreased by RM0.14 million or 2.14% to RM6.39 million from RM6.53 million in Q1 2020, due to the adverse impact brought by the COVID19 pandemic and the resultant MCO.

    Helpful(0) Unhelpful(0)You have already voted this
  5. Avatar

    REMUNERATION STUDY

    In Financial Year End 2019, the directors’ remuneration was 2.43 million. It was slightly high compared to average in listed companies, considering the employees’ remuneration of 7.3 million and auditor’s remuneration of 203 thousands

    Helpful(0) Unhelpful(0)You have already voted this
  6. Avatar

    BURSA MALAYSIA

    The revenue for the first (1st) quarter ended 31 March 2020 decreased by RM11.88 million or 6.54% to RM6.53 million from RM18.41 million in the fourth (4th) quarter ended 31 December 2019, due to seasonality factor that was further exacerbated by the COVID-19 pandemic and the resultant MCO. The Group’s business activities are subject to seasonal trends where the first (1st) quarter performance is usually the softest due to fewer working days as a result of festive holidays.

    Helpful(0) Unhelpful(0)You have already voted this
  7. Avatar

    Investing Malaysia

    Average investing volume for Bioalpha Holdings Bhd in the past three months in stock market was 1998.9k lots

    Helpful(0) Unhelpful(0)You have already voted this
  8. Avatar

    Investing Malaysia

    BIOHLDG gets a score of 25.05 in our equity and assets quality test based on current share price of RM0.165

    Helpful(0) Unhelpful(0)You have already voted this
  9. Avatar

    Investing Malaysia

    Bioalpha Holdings Bhd gets a score of 22.36 in our stability test after the balance sheet, money statement study

    Helpful(0) Unhelpful(0)You have already voted this
  10. Avatar

    Investing Malaysia

    Stock code of 0179 in Bursa Malaysia declared adjusted 0.26% dividend yield in past few years

    Helpful(0) Unhelpful(0)You have already voted this
  11. Avatar

    Investing Malaysia

    BIOHLDG is estimated to have a profit consensus of 15.72 millions, with an adjusted market capitalization of 144.09 millions

    Helpful(0) Unhelpful(0)You have already voted this
  12. Avatar

    REMUNERATION STUDY

    In Financial Year End 2018, the directors’ remuneration was 2.33 million. It was slightly high compared to average in listed companies, considering the employees’ remuneration of 7.8 million and auditor’s remuneration of 162 thousands

    Helpful(0) Unhelpful(0)You have already voted this

    Add a review

    Your email address will not be published.

    BIOHLDG 0179

    PREVCLOSECHANGEHIGHCLOSE
    0.2550.260+0.0050.2650.255

    VOLUMEBUY VOLBUYSELLSELL VOL
    126,2675,2300.2600.26522,374

    klse share price, target price, profit PER estimation
    Register New Account
    Name (required)
    Reset Password
    Compare items
    • Total (0)
    Compare